Related Experiment Videos
Preliminary report of a multi-center study on the West syndrome
R Nolte1, H J Christen, J Doerrer
1University Children's Hospital, Tübingen, West Germany.
Insights
West syndrome in infants is often linked to prenatal/perinatal causes and developmental delays. Early behavioral signs are key indicators. ACTH/steroid treatments showed better outcomes than other regimens, despite risks like hypertension and infections.
Area of Science:
- Pediatric Neurology
- Developmental Neuroscience
- Clinical Pediatrics
Background:
- West syndrome, a severe infant epilepsy, presents with specific seizure patterns and developmental issues.
- Etiologies are often prenatal or perinatal, leading to significant neurological deficits.
- Early identification of characteristic behavioral abnormalities preceding spasms is crucial.
Purpose of the Study:
- To comprehensively evaluate clinical findings and current treatment modalities for West syndrome in infants.
- To analyze the spectrum of seizure manifestations and developmental impacts.
- To assess treatment responses and adverse reactions to guide future therapeutic strategies.
Main Methods:
- A 12-month observational study involving 54 infants with West syndrome across 10 major children's hospitals.
- Data collection focused on clinical presentation, etiology, neurological status, and psychomotor development.
- Evaluation of various therapeutic interventions, including ACTH/steroid and non-ACTH/steroid regimens.
Main Results:
- Prenatal and perinatal factors were prevalent etiologies.
- Severe neurological deficits and disturbed psychomotor development were common.
- ACTH/steroid treatments demonstrated a more favorable response compared to non-ACTH/steroid regimens.
- Arterial hypertension and infections were the most frequent serious adverse reactions.
Conclusions:
- West syndrome necessitates detailed initial patient assessment and systematic monitoring.
- Therapeutic strategies require improvement, balancing efficacy with adverse event management.
- Further trials are needed to optimize treatment protocols for West syndrome.
Abstract:
During a 12-month period, 54 infants with the West syndrome (10 idiopathic, 44 symptomatic) referred to 10 major children's hospitals for initial treatment were evaluated to obtain comprehensive data on clinical findings and current treatment modalities. Prominent features included prevalence of prenatal and perinatal etiologies, severe neurological deficits and disturbed psychomotor development as well as patient-specific spectrum of seizure manifestations. Characteristic behavioural abnormalities before onset of spasms are an early indicator for the West syndrome. Therapeutic management varied considerably. Response to ACTH/steroid regiments was more favourable than to non-ACTH/steroid regimens. The most frequent serious adverse reactions during the initial treatment period were arterial hypertension and infections. Improved therapeutic strategies based on detailed initial patient assessment and systematic monitoring of beneficial effects and adverse reactions are necessary for future trials.